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Abstract  
Technological innovations vary considerably in terms of novelty and impact with only a minority 
of new inventions contributing considerably to economic growth. More recently a number of 
patent-based indicators have been advanced to capture the different characteristics of 
technologically important inventions among which the notion ‘radical’ figures prominently. 
Radical inventions combine a high degree of novelty with a significant impact on future 
technology trajectories. Within this contribution, we compare and validate these indicators 
within the field of biotechnology. An extensive analysis of the recent history of biotechnology 
allows to identify important inventions (n=290) for the time period 1976 – 2001. A considerable 
number of these inventions have been patented between 1976 and 2001 (n= 216; 75%). For all 
USPTO biotech patents filed between 1976 and 2001 (n= 84,119) relevant indicators have been 
calculated. Within a next step, logistic regression models are used to assess which indicators 
allow to distinguish between important, radical, inventions and their less noticeable counterparts. 
Our findings suggest the relevance of using multiple, complementary, indicators to capture the 
multidimensional nature of technological radicalness whereby ex post indicators clearly 
outperform ex ante indicators in terms of precision and recall. 
Introduction: Some inventions are more radical than others 
While the importance of technological innovation is widely acknowledged in terms of wealth 
creation, both on the level of economies and firms, the nature and impact of technological 
inventions vary widely. While some new technologies imply a relatively small extension of prior 
art, others completely disrupt or reshape the technological landscape of a field. In this respect, a 
variety of relevant distinctions have been advanced to delineate important inventions ranging 
from radical to revolutionary, breakthrough, discontinuity and disruptive. Important or radical  
inventions introduce new concepts that depart significantly from past practices, have the 
potential to disrupt existing markets, generate new markets and elicit follow-up innovations. As 
such, they can be seen as critical building blocks of a company’s or nations’ creative destruction 
capacity and long-term economic growth.   
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In general, the definitions of radical innovation used in the management literature tend to 
characterize “radicalness” both in technological and in economic terms. Adopting a 
technological perspective, radical innovations are based on a different set of science and 
engineering principles than existing technologies (Henderson & Clark, 1990), and/or incorporate 
substantially different core technologies (Chandy & Tellis, 2000). Radical innovations are also 
described as innovations that serve as the basis for many subsequent technological developments 
(Ahuja & Lampert 2001), representing a significant leap forward in the technological frontier.  
Along the economic dimension, radical innovations are listed as adding significant new value to 
the marketplace (Tushman & Anderson, 1986). Finally, radical innovations have been defined in 
terms of the profound impact they have on firms, industries and markets. Utterback (1994) 
defined radical innovations or discontinuous change as “change that sweeps away much of a 
firm’s existing investments in technical skills and knowledge, designs, production technique, 
plant and equipment,” and Henderson (1993) described an innovation as being radical when it 
renders a firm’s information filters and organizational procedures (partially) obsolete.  In the 
evolutionary economics tradition, “radical innovation” is commonly evoked within typologies 
that attempt to characterize a product’s or process’ degree of innovativeness (Dosi, 1982). 
Freeman (1992) proposed a taxonomy for technological innovation involving four levels of 
change: incremental innovation, radical innovation, changes of technical systems, and changes of 
techno-economic paradigms. Radical innovations, according to Freeman, are discontinuous 
events, where the discontinuity occurs in the production system. Changes of technical systems 
involve far-reaching changes in technology and affect different parts of the economy, ultimately 
leading to entirely new sectors. These can involve clusters of radical innovation. 
 
The variety of definitions that are being advanced are to some extent problematic for the 
innovation research community because it complicates the construction of indicators for measuring 
radical innovations. A first important distinction among definitions relates to technological or 
commercial perspectives as outlined above. The literature has mainly focused on the commercial 
perspective by studying the competitive dynamics caused by radical innovation without a proper 
understanding of the actual sources of technologically radical inventions. By consequence, large 
scale empirical evidence on the origins of radical technology remains rather limited. Most work in 
the field is rather case-study based or limited in scope, typically focusing on a carefully selected 
generation of technologies, industry and a specific time period.  
 
In the last two decades, several patent-based indicators have been advanced to assess the radical 
nature of technological inventions. Patents contain detailed information on the nature of the 
technology and leave a paper trail of patent citations, forward citations and backward citations. 
This information allows to trace at least parts of the origin of ideas as well as their influence 
(when they directly or indirectly serve as prior art). Patent citations also give an indication of the 
economic value of patents (Griliches, 1984; Jaffe & Trajtenberg, 2002). These features make 
patents particularly interesting for identifying technologically radical inventions. Our 
contribution builds on the proposed patent-based measures in the literature and aims to arrive at a 
set of indicators that allows to identify technologically radical inventions. In order to do so, we 
engage in validation efforts within the field of biotechnology whereby a mapping of the 
development of the biotechnology field between 1976 and 2001 results in a list of 
technologically radical inventions. Within a next step, most notable indicators used in the 
literature are calculated for all granted USPTO biotech patents (time period 1976-2001). Finally, 
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we rely on logistic regressions models to assess which indicators allow to identify the radical 
nature of inventions. Our findings reveal that combining available indicators allows to classify 
over 80% of patents correctly. Ex post indicators clearly outperform indicators of an ex ante 
nature.   
 
The remainder of the paper is outlined as follows. First, we introduce the indicators used in this 
analysis. Next, we provide a short overview of the field of biotechnology, our sample selection 
and methods to identify important, radical inventions. Afterwards, we discuss the descriptive 
statistics and results from multivariate analysis. We conclude with discussing implications as 
well as directions for further research.  
 
Patent Indicators that assess technological radicalness 
Different indicators relying on patent data have been used in the literature to assess the nature 
and impact of patented inventions. To assess the nature of an invention, patents can be compared 
in terms of backward citations, technology classes or both. Patents without backward citations to 
technical prior art have been labeled pioneering (Ahuja & Lampert, 2001) while dissimilar 
patents have been defined as displaying a backward citation structure which is different 
compared to prior patents in the field (Dahlin & Behrens, 2005). The originality of a patent can 
be identified through the technology fields of a patent’s backward citations with original patents 
relying on prior art from a broad range of technology fields (Trajtenberg & al., 1997). Finally, 
more creative inventions have been identified as displaying a novel combination of technology 
subclasses (Fleming & al., 2007).  
 
To assess the impact of the patent on further technology development, scholars have primarily 
used forward citations, backward citations and technology classes. The number of citations a 
patent receives reflects its direct impact on future technologies (Gambardella & al., 2008) while 
a similar backward citation structure between a patent and later inventions reflects adoption 
(Dahlin & Behrens, 2005). Patents which are cited by patents from different technology fields 
are considered to have a more general impact (Trajtenberg & al., 1997). Finally, technologies 
with a novel combination of technology subclasses are adopted by the larger community in case 
the same combination of subclasses is frequently used by future patents (Fleming & al., 2007) 
 
Indicators relying on the distribution of forward citations 
The most popular indicator of patent impact or value is the number of forward citations received 
from future patents. The number of forward citations a patent receives is related to its 
technological importance (Albert & al., 1991; Carpenter & al., 1993; Jaffe & al., 2000) as well 
as its social (Trajtenberg, 1990) and private value (Harhoff & al., 1999; Hall & al., 2005). 
Although forward citations carry a lot of noise,1
                                                 
1 E.g. forward citations are also influenced by patent renewal behavior (Harhoff & al., 1999) and the occurrence of 
patent opposition (Lanjouw & Schankerman, 1999). 
 it proxies the estimated economic value as 
evidenced by an inventor-targeted survey (Gambardella & al., 2008).  The distribution of 
forward citations is very skewed with a large share of patents receiving no citations and a small 
minority of patents with a large number of forward citations. This pattern resembles the 
distribution of the actual value of inventions which is also very skewed. Hence, it is likely that 
outliers in the distribution of forward citations pertain to more important inventions. To create a 
 85 
relevant indicator, we calculate for all granted US patents the count of forward citations as the 
number of US patents citing the patent (patents granted in 2006 inclusive) and the truncated 
count of forward citations as the number of citations received within 5 years after application. 
Prior research has typically identified breakthrough patents as the top 1% or 5% in terms of 
citation received compared to patents with the same application year and technology class (e.g. 
Ahuja & Lampert, 2001; Singh & Fleming, 2010). This definition assumes each technology field 
to have a fixed share of high impact inventions each year and does not compare patents across 
years. To avoid a definition that forces a fixed proportion of breakthroughs every year in each 
class while allowing similar patents to be compared across years, we look at the distribution of 
both forward citations received within 5 years and the distribution of forward citations received 
from all future patents until 2006. We use the full count of forward citations to compare all 
patents sharing at least one 3-digit technology class filed within the same year and the truncated 
citation count to compare all patents sharing at least one 3 digit technology class irrespectively of 
their time of filing. For each of the distributions, we calculate the mean and standard deviation of 
forward citation counts. A patent is labeled as having a big impact in case both its truncated and 
full count of forward citations are larger than the mean plus n times the standard deviation in at 
least one of its technology classes. So for each technology class of a patent, the patent is 
compared with 2 distributions, the distributions of full and truncated forward citation counts. 
Using a 1, 2, 3, 5 and 10 standard deviation definition, we respectively find 6%, 3%, 1%, 0.5% 
and 0.09% of biotechnology patents in our sample to be labeled as having a disproportionate 
impact on future patents. 
 
Indicators relying on the first and successful combination of technology subclasses  
New technology can almost always be traced back to a combination of preexisting ideas or 
technologies (Nelson & Winter, 1982; Basalla, 1988). Fleming (2001) argues that a patent’s 
technology subclasses capture the different components used to assemble the technology. To 
identify particularly original contributions with a potentially high impact on future technology 
development, Fleming & al. (2007) identify patents which are the first to combine 2 particular 
technology subclasses. To assess the diffusion or adoption of the technology, they look at the 
number of future patents which use the same pairwise combination of technology subclasses. We 
use the 2008 US technology subclass concordance to go through all technology subclass 
assignments of all US granted patents and identify the first pairwise subclass combination and 
the number of future patents which use this pairwise combination. In our sample of biotech 
patents, we find 44% of patents to have a new combination of subclasses with on average 54 
future patents using the same pairwise combination of subclasses (among patents who make a 
new combination). 
 
Indicators relying on a dissimilar, unique and adopted backward citation structure 
A third way to identify technologically radical inventions was developed by Dahlin and Behrens 
(2005) using backward patent citations to other USPTO patents. By calculating the overlap 
scores between the backward citations of each patent P granted in year t with all other granted 
patents2
                                                 
2 To calculate the overlap score between patent A and B, the number of overlapping backward citations of A and B 
is divided by the total number of backward citations of A and/or B. Only citations to patents granted in a year before 
the minimum grant year of A and B are taken into account. 
 in the same field and averaging these overlap scores within each year relative to the 
grant year t, one can identify which patents have a dissimilar citation structure with respect to 
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prior art (in our case, patents granted in t-n with 0<n<=5), a unique citation structure with respect 
to patents granted in year t and a citation structure which gets adopted by future patents (granted 
in t+n with 0<n<=5). A patent is labeled radical in case its backward citation structure is 
dissimilar, unique and gets adopted by future patents. This definition resembles the definition of 
Fleming et al. (2007) but uses backward citations rather than technology subclasses. We follow 
the methodology of Dahlin and Behrens (2005) and calculate for each patent average annual 
overlap scores between the backward citations of the patent with respectively all other patents 
filed in the same field (3 digit technology class) within a time window of 5 years before and 5 
years after the grant year. We extent the methodology by comparing a patent to all other US 
granted patents with at least one similar 3 digit technology class. So for each of a patent’s 3 digit 
technology classes, we follow the methodology as outlined in Dahlin and Behrens (2005).  First, 
we label a patent as being discontinuous with prior art in case the standardized average annual 
overlap score is 0 or smaller than or equal to the 10th percentile of all patents for each year t-n 
relative to their grant year. Due to truncation, not all patents have a time window of 5 years 
before (and after) grant. For patents which we can only observe 3 or 4 years before grant, we 
require the patent’s standardized overlap score to be 0 or at or below the 10th percentile 
threshold for each of the observed years before grant. Patent which can’t be observed at least 3 
years before and after the grant are not taken into account during the analysis. Following this 
methodology, 38% of the patents in our sample have a dissimilar citation structure. Second, a 
patent is labeled as unique in case the average standardized overlap score in the year of grant is 
below or equal to the 10 percentile threshold. We find 66% to pass the uniqueness criteria. Third, 
a patent is labeled as adopted in case the annual overlap score passes the 90th percentile threshold 
for each year after grant. 7% of the patents is our sample pass the adoption criteria. Finally,  
2.1% of the patents pass all 3 criteria and are labeled radical.  
 
Indicators capturing originality and generality 
Trajtenberg & al. (1997) develop a backward and forward looking measure of the basicness of an 
invention. The former capturing the nature of the research itself, the latter capturing the nature of 
the research outcome. Originality captures the extent to which the nature of the research 
underlying the patent is based on prior art in a broad range of fields suggesting it seeks to find 
general laws rather than solving particular technical questions (Trajtenberg & al., 1997).  
Generality captures the extent to which the outcome of the research serves as prior art for a broad 
range of technology fields. Originality is calculated as 1- bias-corrected3
 
 Herfindahl index of 
technological classes (3 digit) of all cited patents (Hall & al., 2001). Generality is calculated as 
1- bias-corrected Herfindahl index of technological classes (3 digit) of all citing patents. 
Biotechnology 
Definition and short history 
According to Bud (1993),  the term biotechnology was coined as long ago as the year of the 
Russian revolution, 1917. Today, the best known definition is perhaps the one spelled out by the 
Organization for Economic Co-operation and Development (OECD, 2005): “Biotechnology is 
the application of scientific and engineering principles to the processing of materials by 
biological agents to provide goods and services.” Contrary to its name, biotechnology is not a 
single technology. Rather it is a group of technologies that share two characteristics, working 
with living cells and their molecules and having a wide range of practical uses that can improve 
our lives (Keener & al., 2012). 
                                                 
3 A bias correction is necessary as not all patents have the same number of technology classes. 
 87 
This paper focuses on the period from 1976 to 2001. By the 1950s large scale production of for 
example beer, cheese, citric acid, pharmaceuticals and other products of social and economic 
relevance such as antibiotics had become well established. During that time biotechnology 
benefited from major public funding and increasing economic impact. Major technical 
accomplishments and progress were achieved during the late 1970s and 1980s, most notably due 
to genetic research and recombinant technologies. A milestone was the model of DNA as the 
molecular basis of heredity derived by Watson and Crick with the aid of data provided by 
Rosalind Franklin who worked in Maurice Wilkin’s X-ray crystallography laboratory in 1953 
(Watson & Crick, 1953). However, the DNA revolution as Hotchkiss (1979) termed it, 
progressed or penetrated slowly into technology, initially having little effect on traditional 
processes and products. A significant change has been triggered by the introduction of 
recombinant DNA (Cohen, Chang & Hsu, 1972; Cohen & Boyer, 1979/1980). The emergence of 
molecular biology and biochemical engineering coincides with a growing industrial interest and 
the range of products expanded significantly.  
 
The integration of applied microbiology, biochemical engineering and molecular biology led to 
the creation of biotechnology as a scientific discipline on its own with a common paradigm at the 
level of molecular research. Sub-disciplines such as genomics, transcriptomics, proteomics, 
metabolic flux analysis with quantitative analysis of complex metabolic pathways and finally 
biochemical engineering and bioinformatics have merged to create biosystems engineering 
(Sinskey, 1999; Stephanopoulos, 1999; Reuss, 2001).  
 
Identification of technologically radical inventions 
In order to establish a timeline of this period within the history of biotechnology with all the 
major technological developments, we relied on secondary sources including books, journal 
articles, websites and expert reports on the development of the field. Amongst those sources, we 
mainly relied upon scientific books. In fact, many interesting books provide a consistent and 
exhaustive overview of all major events and accomplishments of biotechnology or a particular 
subfield. We verified multiple secondary sources to strengthen the overall consistency of our list 
of radical inventions because any synthesis might be conditioned by the personal interests or 
values of the authors. We concentrated on events pointed out by terms such as “discontinuous,” 
“pioneering,” “breakthrough,” “revolutionary,” “radical,” “drastic,” “cutting edge,” 
“fundamental,” “groundbreaking,” “dramatic,” “leap forward,” “original” amongst others. 
Furthermore, priority was also given to those inventions which were described as contributing to 
the evolution of the field as a whole, highlighting fundamental leaps on certain key research 
trajectories or establishing new ones as clearly stated by authors.  
 
Linking technologically radical inventions to patents 
After carrying out a comprehensive screening and assessment of radical inventions in biotech, we 
identified patents and publications associated with those inventions. Using information on the 
description and timing of the invention, the authors, institutions and/or companies, we searched for 
corresponding patents and publications in the USPTO patent database and the ISI Web of Science 
respectively. In some cases we found more than one corresponding patent and/or more than one 
corresponding publication. Of the 290 externally identified inventions, 216 (75%) were identified in 
the patent system and 138 (48%) were found in the WOS database as scientific publications. For 
152 (52%) of the events we only found at least one corresponding patent, for 74 (26%) we only 
found a publication while for 64 (22%) we found patent-paper pairs. For 10 events, we found multi-
ple corresponding patents. A detailed list of the identified USPTO patents is available upon request.  
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Data and findings 
Sample Selection 
To identify all USPTO biotechnology patents, we made use of the OECD classification based on 
IPC codes (OECD, 2005). Data have been extracted from the Patstat patent database and imply 
all patents filed at the USPTO between 1976 and 2001 and granted before 2004 which fall into at 
least one of these IPC classes. The final sample used for analysis consists of 84,119 patents. Out 
of the 84,119 patents, 198 are externally validated as being radical. 17 of the validated radical 
patents were not classified as biotech according to the OECD definition based on IPC codes. For 




Table 1 gives an overview of descriptive statistics for the validated set of radical patents and for 
the control patents including a mean-comparison T-test between the 2 groups.  
 
We will first discuss the differences in indicators reflecting novelty with respect to prior art and 
discuss descriptive statistics on the indicators reflecting impact afterwards. We do not find 
significant differences in the proportion of patents without citations to technical prior art. By 
contrast, radical patents seem to more frequently cite other patents compared to the control group 
(14 backward patent citations compared to 6 on average). Furthermore, radical patents  have a 
more dissimilar backward citation structure compared to prior art in the same area (54% of 
dissimilar patents compared to 46% for the control group) and rely on more recent technical 
prior art with an average backward citation lag of 6.14 years versus 7.5 years for the control 
group. However, radical and non-radical patents are not different in originality reflecting the fact 
that the research underlying the patent is not based on prior art in a broader range of fields. 
Nevertheless, the radical patents themselves have a larger number of technology (sub)classes so 
they seem to cover a larger part of the technology landscape serving a more general purpose 
(2.65 main classes and 7.96 subclasses on average compared to 2.19 and 6.25 respectively). 
Finally, radical technologies seem to have a much larger number of citations to non-patent 
literature (45 versus 22 on average), are more likely to have a novel pairwise combination of 
different technology subclasses (63% versus 45% on average) and have a larger number of 
claims (22 versus 15 on average). In conclusion, radical patents seem to cite more and more 
recent patents, have a dissimilar citation structure compared to prior art, do not rely on a prior art 
from a broader range of fields but seem to serve themselves a more general purpose by covering 
more fields and claims, and are more likely to combine previously unconnected subfields.  
 
Besides being based on a different set of science and engineering principles and/or incorporating 
substantially different core technologies, radical technologies should also have a big impact on 
future technology trajectories. We do find strong support that radical patents outperform the 
control group in terms of impact. The radical patents receive significantly more forward citations 
on average (105 citations compared to 7 for non-radical patents). Accordingly, looking at outliers 
in the distribution of forward citations we find for instance 60% of the radical patents to be a 1 
standard deviation outlier compared to 7% for non-radical patents and 20% to be a 10 standard 
deviation outlier compared to 0.05% for the control group. Besides serving more as prior art for 
future generations of technologies, they also tend to remain cited for a longer time (takes more 
                                                 
4 see https://sites.google.com/site/patentdataproject/Home 
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time to get cited or remain cited for a longer time) with an average forward citation lag of 7.46 
years compared to 5.87 for the control group. Furthermore, radical inventions seem to serve as 
prior art for a broader range of technology fields so tend to have a more general impact with an 
average generality score of 0.71 compared to 0.51 for the non-radicals. Among patents which 
make a new pairwise combination of previously unconnected fields, we find the pairwise 
combination of radical patents to be adopted by a much larger number of future patents. On 
average, 1,511 future patents will use the same component configuration compared to 44 future 
patents for the control group. Besides a large adoption of the novel combination of subclasses, 
radical patents’ backward citation structure seems also more likely to be adopted by future 
patents with 38% of radical patents having an adopted backward citation structure compared to 
7% of non-radical patents. 
 
Dahlin and Behrens (2005) suggest to use a composite measure to identify technologically 
radical inventions. Besides having a citation structure which is dissimilar with prior art and gets 
adopted by future patents, they add an additional “uniqueness” criteria of having a citation 
structure which is different from patents granted in the same year. We find radical patents to 
have a citation structure which is less unique with 59% of the radical patents satisfying the 
uniqueness criteria compared to 67% for the control patents. According to the authors, 
technologically radical inventions should satisfy all 3 criteria. We find 17% of our radical 
inventions to satisfy all 3 criteria compared to 2% for the control group. 
 
Table 2 presents the correlation coefficients between most notable indicators. The dummies 
representing outliers in the distribution of forward citations seem most correlated with being a 
technologically radical invention. Also, the number of future patents using the same pairwise 
combination of subclasses displays a strong correlation. 
 
In conclusion, these descriptive results suggest both backward looking measures reflecting 
novelty as well as forward looking measures of impact are indicative of radicalness. Particularly 
measures reflecting impact seem to reveal discriminatory power. 
 
Multivariate analysis 
Given that our dependent variable is binary (0/1) indicating whether the patent was identified as 
being a major contribution to the field, we use logit models to assess the discriminatory power of 
different indicators previously suggested in the literature. Given that a radical patent is a rare 
event, we alternatively estimate the model with a rare even logit model (King & al., 2001). All 
models include technology dummies for each of a patent’s main technology classes (3digit) as 
well as a set of additional control variables including the number of assignees, the number of 
inventors, the number of citations to other patents and to non-patent literature, the number of 
claims, the number of technology main and subclasses and patent age. Notice that patents in a 
technology class without radical patents are dropped from the analysis during estimation. To 
assess the discriminatory power of the different indicators to identify (non)radical patents, we 
provide a number of statistics below each regression model in table 3. We are particularly 
interested in the sensitivity of the model, the % of radical patents which are predicted to be 
radical (so–called recall), as well as in the positive predicted value, the % of patents predicted to 
be radical which are radical (so-called precision).  
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Table 3 present the results on the full set of patents. Notice that a radical invention is a very rare 
event, with only 0.27% of all patents being radical, seriously hampering the assessment of the  
precision and recall qualities of the models (any model that would use the rule ‘all patents should 
be considered as not important/radical’ would classify over 99% of all patents correctly). 
Therefore, we present parallel results for a reduced sample of matched patents in table 4. Using 
coarsened-exact matching (Iacus & al., 2009) to generate a more balanced sample of patents, we 
only keep control patents with exactly the same technology classes, application year and grant 
year as at least one of the radical patents. Radical patents for which no proper match is found are 
also excluded from the analysis. For each remaining radical patent, we randomly sample 4 
control patents among those which match and rerun the model on the reduced sample. 
 
In the full sample, we find the dummies indicative of being an outlier in the distribution of 
forward citations to have the most predictive power of all indicators. Patents which are a 1 
standard deviation outlier in the distribution of forward citations are 146% more likely to be 
radical inventions while 10 standard deviation outliers are 627% more likely to be radical.5 The 
stricter the criteria of being an outlier, the more predictive power.6
                                                 
5 Marginal effects are calculated as the % change with respect to the average likelihood to be radical, i.e. 0.2661%.  
 Recombining previously 
unconnected technology subclasses doesn’t makes a patent more likely to be radical. 
Nonetheless, the number of future patents adopting the same subclass combination is a 
significant predictor, with an increase in 100 future patents adopting the same combination being 
associated with a predicted increase of 8%. Column 3 present the findings for the different 
measures suggested by Dahlin and Behrens (2005). We find patents dissimilar to prior art in 
terms of backward citations 37% more likely to be radical. Surprisingly, the uniqueness dummy 
has a negative impact suggesting that breakthroughs have similar backward citations to patents 
filed in the same year and class compared to non-breakthroughs. This might indicate that similar 
attempts building on the same prior art are conducted during the same time period while only one 
of these attempts is successful. Furthermore, radical patents do have a citation structure which 
gets adopted by future patents. This effect is very strong, a citation structure which shows a 
strong overlap with future patents increases the expected probability of being radical with 116 % 
while we don’t find support for a significant impact of dissimilarity, uniqueness and adoption. 
Column 4 present results for the originality and generality measures. Radical inventions clearly 
serve a general purpose as technical prior art but don’t seem to rely themselves on technical prior 
art from a broad range of fields. An increase of 0.1 in generality is associated with an expected 
increase of 60%. Finally, we present the results for all ex ante indicators reflecting 
dissimilarity/novelty (column 5), ex post indicators reflecting impact (column 6) and both 
combined (column 7). As expected, it is much harder to identify radical patents before observing 
their impact. The measures reflecting direct use as prior art through forward citations, indirectly 
reflecting adoption through subclass combination and backward citations have much more 
predictive power. Therefore, combining both ex ante and ex post indicators present itself as the 
preferred option. The final model (column 7) combing all indicators is able to identify 1 out of 4 
radical patents while 3 out of 4 positive predicted patents is actually radical. Hence, the models 
are pretty conservative. Given that logit models tend to underestimate the likelihood of rare 
event, we try using a less restrictive classification and take a predicted probability of 0.05 or 
larger as cut off for being radical. This results in 46% of all radical inventions to be identified but 
only 22% of the positive predicted patents is actually radical.  
6 Notice that more conservatively defined outliers are also less conservatively defined outliers. For instance, a patent 
which is a 3SD outlier is also a 2 and 1 SD outlier.  
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Table 4 presents the regression results for the matched sample of patents. Besides a few notable 
exceptions, results are pretty similar. Being a 10 standard deviation outlier in the distribution of 
forward citations is a very strong predictor of radicalness given that not a single non-radical 
patent belongs to this category. Therefore, 21 of our radical patents are dropped from the 
analysis. In contrast to the full sample, having a dissimilar backward citation structure is not 
significant anymore. The full model (column 7) combining all indicators is able to identify 55% 
of the radical patents while 83% of the patents predicted to be radical are indeed radical.  
 
Discussion and (intermediate) conclusion 
By identifying technologically radical inventions in the field of biotechnology, it becomes 
feasible to examine whether and to what extent proposed indicators actually assess the 
radicalness of inventions. Indicators advanced so far can be labeled as ‘ex ante’ to the extent that 
the indicator can be calculated as soon as the invention appears as a patent publications (e.g.  
novelty of backward citation patterns, technology class combination). A number of indicators 
however can only be assessed ‘ex post’ (e.g. number of received citations, number of patents 
displaying similar citation patterns afterwards). Our results reveal that relying on ‘ex post’ 
indicators allows to identify important, radical inventions more accurately (87 % correctly 
classified, versus 80%). 
 
As such, some of the recent proposed indicators, relying heavily on ‘novelty’ do not qualify as 
accurate predictors of radical or important contributions to the field.  Using ex ante indicators 
only, seems problematic. Finally, it can be noted, that the number of NPR’s, included as a 
control variable, display some predictive power in terms of radicalness.  
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Appendix–Result Tables 
Table 1. Descriptive Statistics. 
 
 
 Final sample  
198 Radical (0.2354%)  
 Radical n Mean SD Pr(|T| > 
|t|) 
Forward Citation Count 0 83921 6.90 13.98 0.0000 
 1 198 104.96 183.60  
Forward Citation Count 5y 0 83921 2.80 5.40 0.0000 
 1 198 26.97 40.42  
Outlier 1SD class & class year 0 83921 0.07 0.25 0.0000 
 1 198 0.60 0.49  
Outlier 2SD class & class year 0 83921 0.03 0.17 0.0000 
 1 198 0.49 0.50  
Outlier 3SD class & class year 0 83921 0.01 0.12 0.0000 
 1 198 0.36 0.48  
Outlier 4SD class & class year 0 83921 0.01 0.09 0.0000 
 1 198 0.30 0.46  
Outlier 5SD class & class year 0 83921 0.00 0.07 0.0000 
 1 198 0.28 0.45  
Outlier 10SD class & class year 0 83921 0.00 0.02 0.0000 
 1 198 0.20 0.40  
No Forward Citations 0 83921 0.26 0.44 0.0000 
 1 198 0.04 0.20  
Forward Citation Lag 0 62230 5.87 3.54 0.0000 
 1 190 7.46 3.62  
Generality 0 83921 0.51 0.28 0.0000 
 1 198 0.71 0.12  
Count Claims 0 83895 15.42 15.18 0.0000 
 1 197 21.98 20.05  
Count main technology classes 0 83921 2.19 1.04 0.0000 
 1 198 2.65 1.25  
Count technology subclasses 0 83921 6.25 4.42 0.0000 
 1 198 7.96 6.54  
First Subclass Combi Dummy  0 83921 0.45 0.50 0.0000 
 1 198 0.63 0.48  
First Subclass Combi Count Re-Use 0 37931 43.97 188.39 0.0000 
 1 125 1510.59 4654.71  
Count Backward Citations 0 83921 5.86 12.71 0.0000 
 1 198 14.18 42.60  
No Backward Citations  0 83921 0.19 0.39 0.1948 
 1 198 0.16 0.36  
Backward Citation Lag 0 67515 7.51 4.05 0.0000 
 1 167 6.14 3.08  
Originality  0 83921 0.52 0.27 0.2591 
 1 198 0.54 0.30  
Count Non-Patent References 0 83921 22.42 39.43 0.0000 
 1 198 44.93 53.54  
Dahlin and Behrens dissimilarity (before grant) 0 82893 0.46 0.50 0.0474 
 1 198 0.54 0.50  
Dahlin and Behrens uniqueness (year grant) 0 83921 0.67 0.47 0.0221 
 1 198 0.59 0.49  
Dahlin and Behrens adoption (after grant) 0 83921 0.08 0.26 0.0000 
 1 198 0.38 0.49  
Dahlin and Behrens composite  0 82893 0.02 0.14 0.0000 
 1 198 0.17 0.38  
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Table 2. Correlation Matrix. 
 
 
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) 
(1) Patent radical 1             
(2) Outlier 1SD class & class year 0.0983* 1            
(3) Outlier 2SD class & class year 0.1303* 0.6399* 1           
(4) Outlier 5SD class & class year 0.1771* 0.2690* 0.4204* 1          
(5) Outlier 10SD class & class year 0.2967* 0.1179* 0.1843* 0.4383* 1         
(6) First Subclass Combi Dummy 0.0192* 0.0852* 0.0653* 0.0333* 0.0203* 1        
(7) First Subclass Combi Count Re-Use 0.2300* 0.0436* 0.0451* 0.0424* 0.0716* 0.0892* 1       
(8) D&B dissimilarity (before grant) 0.0087* 0.0269* 0.0154* 0.0074 0.0038 0.1214* 0.0263* 1      
(9) D&B uniqueness (year grant) -0.0078 -0.0408* -0.0324* -0.0164* -0.0075 0.1155* 0.0252* 0.4826* 1     
(10) D&B adoption (after grant) 0.0563* 0.1136* 0.0959* 0.0542* 0.0328* -0.0095* 0.0432* -0.0895* -0.1543* 1    
(11) D&B composite 0.0503* 0.0540* 0.0448* 0.0185* 0.0158* 0.0634* 0.0804* 0.1597* 0.1054* 0.5145* 1   
(12) Generality 0.0334* 0.1696* 0.1145* 0.0552* 0.0295* 0.1028* 0.0202* 0.1155* -0.0495* 0.0725* 0.0431* 1  




Table 3. Radical Patent Full Sample. 
 (1) (2) (3) (4) (5) (6) (7) (8) 
VARIABLES Radical Radical Radical Radical Radical Radical Radical Radical 
Model Logit Logit Logit Logit Logit 
Ex ante  
Logit 
Ex post  
Logit Rare event Logit 
outlier FC 1SD 1.8050***     1.4781*** 1.4830*** 1.5059*** 
 [0.273]     [0.273] [0.278] [0.278] 
outlier FC 2SD 1.3160***     1.1465*** 1.1345*** 1.1035*** 
 [0.286]     [0.289] [0.289] [0.289] 
outlier FC 5SD 0.9630***     0.9249*** 0.9243*** 0.8960*** 
 [0.334]     [0.339] [0.345] [0.345] 
outlier FC 10SD 3.6375***     3.4846*** 3.4944*** 3.2392*** 
 [0.417]     [0.433] [0.437] [0.436] 
First Subclass Combi Dummy  0.1788   0.2261  -0.0285 0.0102 
  [0.175]   [0.163]  [0.195] [0.195] 
First Subclass Combi Count Re-Use  0.0008***    0.0006*** 0.0006*** 0.0006*** 
  [0.000]    [0.000] [0.000] [0.000] 
D&B dissimilarity   0.3835*  0.3517**  0.0671 0.0623 
   [0.197]  [0.176]  [0.235] [0.234] 
D&B uniqueness   -0.7819***  -0.9182***  -0.4239* -0.3990 
   [0.217]  [0.195]  [0.256] [0.256] 
D&B adoption    1.1961***   0.8241*** 0.6590** 0.6276** 
   [0.253]   [0.207] [0.269] [0.269] 
D&B composite    0.3838    0.3487 0.3488 
   [0.331]    [0.382] [0.382] 
Generality    6.2803***  3.4719*** 3.6142*** 3.4860*** 
    [0.992]  [0.828] [0.874] [0.873] 
Originality    -0.0794 0.1159  -0.6440* -0.6285* 
    [0.301] [0.324]  [0.359] [0.359] 
Count assignees -0.1178 -0.1469 -0.0686 -0.1049 -0.0688 -0.1573 -0.1456 -0.1173 
 [0.121] [0.152] [0.130] [0.145] [0.143] [0.118] [0.118] [0.118] 
Count inventors 0.0462 0.0552 0.0538 0.0526 0.0516 0.0396 0.0422 0.0443 
 [0.041] [0.035] [0.033] [0.033] [0.034] [0.043] [0.043] [0.043] 
Count PRS 0.0086*** 0.0051* 0.0008 0.0043 0.0030 0.0074*** 0.0073*** 0.0078*** 
 [0.002] [0.003] [0.005] [0.003] [0.004] [0.002] [0.002] [0.002] 
Count NPRS 0.0027*** 0.0044*** 0.0037*** 0.0040*** 0.0043*** 0.0018** 0.0019** 0.0019** 
 [0.001] [0.001] [0.001] [0.001] [0.001] [0.001] [0.001] [0.001] 
Count claims 0.0068*** 0.0091*** 0.0085*** 0.0075*** 0.0086*** 0.0066*** 0.0070*** 0.0079*** 
 [0.002] [0.002] [0.002] [0.002] [0.002] [0.002] [0.002] [0.002] 
Count tech. classes 1.2121* 1.3607** 1.4463** 1.1134* 1.5160** 1.1107* 1.2185* 1.3257** 
 [0.706] [0.638] [0.614] [0.608] [0.664] [0.655] [0.666] [0.665] 
Count tech. subclasses -0.0132 -0.0263 0.0181 0.0192 0.0159 -0.0446** -0.0426** -0.0456** 
 [0.020] [0.023] [0.017] [0.017] [0.017] [0.022] [0.021] [0.021] 
Patent age -0.1078*** -0.0779*** -0.1159*** -0.1001*** -0.1169*** -0.0794*** -0.0827*** -0.0817*** 
 [0.015] [0.012] [0.013] [0.013] [0.013] [0.016] [0.016] [0.016] 
Technology dummies Yes Yes Yes Yes Yes Yes Yes Yes 
Log Pseudolikelihood -902.00573 -1137.1608 -1148.5955 -1132.8989 -1170.4729 -848.21002 -842.45801  
Pseudo R2 0.3333 0.1595 0.1498 0.1627 0.1336 0.3731 0.3764  
Exp. Pr. >=0.5 as cut off         
Sensitivity Pr( + | BT ) 17.95% 6.15% 1.03% 1.03% 1.03% 23.08% 24.10% 17.95% 
Specificity Pr( - | NBT ) 99.98% 100.00% 100.00% 100.00% 100.00% 99.98% 99.98% 99.98% 
Pos. pred. value Pr( BT | + ) 71.43% 80.00% 100.00% 100.00% 66.67% 75.00% 74.60% 68.63% 
Neg. pred. value Pr( NBT | - ) 99.78% 99.75% 99.74% 99.74% 99.74% 99.80% 99.80% 99.78% 
False + for NBT Pr( + | NBT ) 0.02% 0.00% 0.00% 0.00% 0.00% 0.02% 0.02% 0.02% 
False - for BT Pr( - | BT ) 82.05% 93.85% 98.97% 98.97% 98.97% 76.92% 75.90% 82.05% 
False + for BT Pr( NBT | + ) 28.57% 20.00% 0.00% 0.00% 33.333% 25.00% 25.40% 31.37% 
False - for NBT Pr( BT | - ) 0.22% 0.25% 0.26% 0.26% 0.26% 0.20% 0.20% 0.22% 
Correctly classified 99.77% 99.75% 99.74% 99.74% 99.74% 99.78% 99.78% 99.76% 
Exp. Pr. >=0.05 as cut off         
Sensitivity Pr( + | BT ) 40.51% 14.87% 14.87% 12.31% 11.28% 44.10% 45.64% 22.56% 
Specificity Pr( - | NBT ) 99.56% 99.81% 99.63% 99.72% 99.74% 99.56% 99.56% 99.97% 
Pos. pred. value Pr( BT | + ) 19.65% 17.06% 9.60% 10.39% 10.33% 20.98% 21.55% 64.71% 
Neg. pred. value Pr( NBT | - ) 99.84% 99.78% 99.77% 99.77% 99.76% 99.85% 99.85% 99.79% 
False + for NBT Pr( + | NBT ) 0.44% 0.19% 0.37% 0.28% 0.26% 0.44% 0.44% 0.03% 
False - for BT Pr( - | BT ) 59.49% 85.13% 85.13% 87.69% 88.72% 55.90% 54.36% 77.44% 
False + for BT Pr( NBT | + ) 80.35% 82.94% 90.40% 89.61% 89.67% 79.02% 78.45% 35.29% 
False - for NBT Pr( BT | - ) 0.16% 0.22% 0.23% 0.23% 0.24% 0.15% 0.15% 0.21% 
Correctly classified 99.41% 99.59% 99.40% 99.49% 99.50% 99.42% 99.41% 99.76% 
Observations 74,072 74,072 73,278 74,072 73,278 74,072 73,278 73,278 
Robust standard errors in brackets  
 *** p<0.01, ** p<0.05, * p<0.1 
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Table 4. Radical Patent Matched Sample. 
 (1) (2) (3) (4) (5) (6) (7) 
VARIABLES Radical Radical Radical Radical Radical Radical Radical 





outlier FC 1SD 1.8581***     1.5067*** 1.5762*** 
 [0.420]     [0.479] [0.474] 
outlier FC 2SD 1.4375***     1.4981** 1.4307** 
 [0.553]     [0.593] [0.598] 
outlier FC 5SD 0.8176     0.4734 0.5706 
 [0.798]     [0.785] [0.799] 
outlier FC 10SD        
        
First Subclass Combi Dummy  0.3054   0.3743  0.0445 
  [0.249]   [0.245]  [0.317] 
First Subclass Combi Count Re-Use  0.0006***    0.0005*** 0.0005*** 
  [0.000]    [0.000] [0.000] 
D&B dissimilarity   0.3679  0.2982  -0.0618 
   [0.307]  [0.298]  [0.383] 
D&B uniqueness   -0.6405**  -0.8339***  -0.3543 
   [0.318]  [0.316]  [0.427] 
D&B adoption    0.9331***   0.4368 0.1576 
   [0.341]   [0.406] [0.462] 
D&B composite    0.1826    0.7930 
   [0.588]    [0.625] 
Generality    7.6696***  4.7156*** 4.8108*** 
    [1.466]  [1.313] [1.338] 
Originality    -0.0812 -0.1211  -0.4837 
    [0.409] [0.416]  [0.517] 
Count assignees -0.3485 -0.1318 -0.1509 -0.2373 -0.1512 -0.4080 -0.4106 
 [0.287] [0.153] [0.145] [0.203] [0.158] [0.312] [0.300] 
Count inventors 0.0026 0.0036 0.0126 -0.0066 0.0174 -0.0043 0.0122 
 [0.067] [0.059] [0.058] [0.061] [0.060] [0.071] [0.071] 
Count PRS 0.0286 0.0096 -0.0008 0.0081 0.0047 0.0211 0.0211 
 [0.022] [0.020] [0.021] [0.013] [0.020] [0.017] [0.017] 
Count NPRS 0.0115*** 0.0136*** 0.0127*** 0.0129*** 0.0131*** 0.0112*** 0.0112*** 
 [0.003] [0.003] [0.003] [0.003] [0.003] [0.003] [0.003] 
Count claims 0.0065 0.0269*** 0.0223*** 0.0253*** 0.0251*** 0.0084 0.0084 
 [0.011] [0.008] [0.008] [0.008] [0.008] [0.010] [0.010] 
Count tech. classes 0.4741 0.6639 -0.0763 0.6584 0.7871 0.3870 0.2156 
 [0.647] [0.528] [0.642] [0.490] [0.504] [0.704] [0.747] 
Count tech. subclasses 0.0279 -0.0518 0.0073 0.0189 -0.0239 0.0153 0.0113 
 [0.044] [0.043] [0.037] [0.039] [0.042] [0.052] [0.059] 
Patent age -0.0332 -0.0196 -0.0432** -0.0441** -0.0424** 0.0001 0.0041 
 [0.027] [0.021] [0.021] [0.022] [0.021] [0.029] [0.028] 
Technology dummies Yes Yes Yes Yes Yes Yes Yes 
Log Pseudolikelihood -220.40988 -295.04756 -295.80042 -267.94068 -299.96087 -201.37105 -200.03016 
Pseudo R2 0.2734 0.1225 0.1202 0.2031 0.1079 0.3361 0.3405 
Exp. Pr. >=0.5 as cut off        
Sensitivity Pr( + | BT ) 51.06% 31.48% 30.86% 37.04% 27.16% 55.32% 55.32% 
Specificity Pr( - | NBT ) 95.95% 97.37% 96.96% 95.14% 97.37% 96.36% 96.76% 
Pos. pred. value Pr( BT | + ) 78.26% 79.69% 76.92% 71.43% 77.19% 81.25% 82.98% 
Neg. pred. value Pr( NBT | - ) 87.29% 81.25% 81.05% 82.17% 80.30% 88.31% 88.35% 
False + for NBT Pr( + | NBT ) 4.05% 2.63% 3.04% 4.86% 2.63% 3.64% 3.24% 
False - for BT Pr( - | BT ) 48.94% 68.52% 69.14% 62.96% 72.84% 44.68% 44.68% 
False + for BT Pr( NBT | + ) 21.74% 20.31% 23.08% 28.57% 22.81% 18.75% 17.02% 
False - for NBT Pr( BT | - ) 12.71% 18.75% 18.95% 17.83% 19.70% 11.69% 11.65% 
Correctly classified 85.98% 81.10% 80.64% 80.79% 80.03% 87.24% 87.56% 
        
Observations 614 635 635 635 635 614 614 
Robust standard errors in brackets, outlier FC 10SD is dropped because it predicts radical patents perfectly in the matched sample,  
21observations are dropped from the analysis  
*** p<0.01, ** p<0.05, * p<0 
